2 days ago
Kepler Capital Sticks to Their Buy Rating for Atrys Health SA (A2T)
Kepler Capital analyst Julian Megias maintained a Buy rating on Atrys Health SA (A2T – Research Report) on June 10 and set a price target of €5.00. The company's shares closed last Tuesday at €2.57.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Megias is a 2-star analyst with an average return of 2.4% and a 62.50% success rate.
Currently, the analyst consensus on Atrys Health SA is a Moderate Buy with an average price target of €5.00.
The company has a one-year high of €4.08 and a one-year low of €2.28. Currently, Atrys Health SA has an average volume of 723.
